Vagus nerve stimulation: a new tool for brain research and therapy∗

  title={Vagus nerve stimulation: a new tool for brain research and therapy∗},
  author={Mark S. George and Harold A. Sackeim and A. John Rush and Lauren B. Marangell and Ziad Nahas and Mustafa M. Husain and Sarah H. Lisanby and Tal Burt and Juliet Goldman and James C. Ballenger},
  journal={Biological Psychiatry},

Figures and Tables from this paper

Vagus nerve stimulation for the treatment of depression and other neuropsychiatric disorders

Owing to its novel route into the brain, it has no drug–drug interactions or systemic side effects, and appears to have high long-term tolerability in patients, with low rates of patients relapsing on vagus nerve stimulation or becoming tolerant.

Vagus nerve stimulation (VNS): utility in neuropsychiatric disorders.

The neurobiology involved in VNS is reviewed, the VNS clinical findings to date are highlighted, and potential VNS research opportunities for both clinical and basic investigators are discussed.

Beyond the Treatment of Epilepsy: New Applications of Vagus Nerve Stimulation in Psychiatry

Results of clinical pilot studies involving patients suffering from obesity and Alzheimer's disease indicate that VNS might induce weight loss and improve cognition, and the perspective of VNS as a long-term treatment with the advantage of assured compliance makes it an interesting technique to potentially treat drug-resistant depression.

Vagus nerve stimulation: A new tool for treating depression

Clinical review of VNS therapy, including clinical trial data, side effects, and contraindications indicate that long-term adjunctive VNS may improve the cours of the illness for patients with major affective disorders.

Vagus nerve stimulation for depression: rationale, anatomical and physiological basis of efficacy and future prospects.

There is considerable evidence from both animal and human neurochemical and neuroimaging studies, that the vagus nerve and its stimulation influence limbic and higher cortical brain regions implicated in mood disorders, providing a rationale for its possible role in the treatment of psychiatric disorders.

Vagus Nerve Stimulation: A New Form of Therapeutic Brain Stimulation

An implantable VNS device known as the VNS™ NeuroCybernetic Prosthesis (NCP) System has been used in approximately 9,000 epilepsy patients in Europe and the United States since 1994 and has reduced seizure frequency by an average of 25% to 30%, with minimal side effects.

Transcutaneous Vagus Nerve Stimulation: A Promising Method for Treatment of Autism Spectrum Disorders

It is hypothesized that tVNS may be a promising treatment for ASD, not only for comorbid epilepsy and depression, but also for the core symptoms of ASD.

A review of the new minimally invasive brain stimulation techniques in psychiatry

The history, methodology, and the future of these minimally invasive brain stimulation techniques and their emerging research and therapeutic applications in psychiatry are reviewed.



Reassessment: Vagus nerve stimulation for epilepsy

A July 1997 assessment of the American Academy of Neurology Therapeutics and Technology Subcommittee review of vagus nerve stimulation for epilepsy concluded that it was promising, but not yet established, and a second multicenter, randomized, controlled clinical trial has shown safety and efficacy of VNS for treatment of intractable partial seizures.

Anatomical, Physiological, and Theoretical Basis for the Antiepileptic Effect of Vagus Nerve Stimulation

The vagus provides an easily accessible, peripheral route to modulate CNS function and is likely to relate to effects on the reticular activating system.

An institutional experience with cervical vagus nerve trunk stimulation for medically refractory epilepsy: rationale, technique, and outcome.

In the experience, vagus nerve stimulation has proven to be a safe, feasible, and potentially effective method of reducing seizures in select patient populations, however, the elements of strict definition for the application of the method require further study.

Vagus nerve stimulation therapy for partial-onset seizures

Vagus nerve stimulation is an effective and safe adjunctive treatment for patients with refractory partial-onset seizures and represents the advent of a new, nonpharmacologic treatment for epilepsy.

Long-term treatment with vagus nerve stimulation in patients with refractory epilepsy. The Vagus Nerve Stimulation Study Group E01-E05.

Long-term, open-label vagus nerve stimulation (VNS) provided seizure reduction similar to or greater than acute studies, for median reductions and for those reaching a > or =50% seizure reduction.

Acute blood flow changes and efficacy of vagus nerve stimulation in partial epilepsy

Increased thalamic synaptic activities probably mediate some antiseizure effects of VNS, and future studies should examine neurotransmitter-receptor alterations in reticular and specific thalamus and cerebellum nuclei during VNS.

Vagus Nerve Stimulation for Treatment of Partial Seizures: 1. A Controlled Study of Effect on Seizures

The effectiveness of VNS as treatment for epilepsy patients with refractory partial seizures was confirmed and high VNS was more effective in reducing partial seizure frequency than was low VNS.

Transcranial magnetic stimulation: applications in neuropsychiatry.

Transcranial magnetic stimulation is a promising new research and therapeutic tool, but more work remains before it can be fully integrated in psychiatry's diagnostic and therapeutic armamentarium.